These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6428844)

  • 21. [Mode of action of oral antidiabetic drugs].
    Frey H
    Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1591-5. PubMed ID: 4588814
    [No Abstract]   [Full Text] [Related]  

  • 22. Low-dose oral glyburide reduces fasting blood glucose by decreasing hepatic glucose production in healthy volunteers without increasing carbohydrate oxidation.
    Tayek JA
    Am J Med Sci; 1995 Mar; 309(3):134-9. PubMed ID: 7879817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents.
    Del Prato S; Vigili de Kreutzenberg S; Riccio A; Maifreni L; Duner E; Lisato G; Iavicoli M; Tiengo A
    Diabetologia; 1990 Nov; 33(11):688-95. PubMed ID: 2127573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: normalization of glucose kinetics by short-term fasting.
    Féry F
    J Clin Endocrinol Metab; 1994 Mar; 78(3):536-42. PubMed ID: 8126123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.
    Kolterman OG; Gray RS; Shapiro G; Scarlett JA; Griffin J; Olefsky JM
    Diabetes; 1984 Apr; 33(4):346-54. PubMed ID: 6423429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic sensitivity to insulin: effects of sulfonylurea drugs.
    Del Prato S; Vigili de Kreutzenberg S; Riccio A; Tiengo A
    Am J Med; 1991 Jun; 90(6A):29S-36S. PubMed ID: 1872301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfonylureas in insulin-dependent (type I) diabetes: evidence for an extrapancreatic effect in vivo.
    Pernet A; Trimble ER; Kuntschen F; Assal JP; Hahn C; Renold AE
    J Clin Endocrinol Metab; 1985 Aug; 61(2):247-51. PubMed ID: 3924948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients.
    Riccio A; Lisato G; de Kreutzenberg SV; Marchetto S; Turrin M; Tiengo A; Del Prato S
    Metabolism; 1996 Oct; 45(10):1196-202. PubMed ID: 8843172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J; Gather W; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM.
    Jeng CY; Sheu WH; Fuh MM; Chen YD; Reaven GM
    Diabetes; 1994 Dec; 43(12):1440-4. PubMed ID: 7958496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose metabolism in noninsulin-dependent diabetic patients with experimental hyperthyroidism.
    Bratusch-Marrain PR; Komjati M; Waldhäusl WK
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1063-8. PubMed ID: 3889028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of glyburide on in vivo insulin-mediated glucose disposal.
    Simonson DC
    Am J Med; 1990 Aug; 89(2A):44S-50S; discussion 51S-53S. PubMed ID: 2117389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of glyburide and insulin treatment to decrease leucine flux in obese type II diabetic patients.
    Welle S; Nair KS
    Int J Obes; 1990 Aug; 14(8):701-10. PubMed ID: 2121656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glyburide increases insulin sensitivity and responsiveness in peripheral tissues of the rat as determined by the glucose clamp technique.
    Hirshman MF; Horton ES
    Endocrinology; 1990 May; 126(5):2407-12. PubMed ID: 2109686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of glyburide on beta cell responsiveness to glucose in non-insulin-dependent diabetes mellitus.
    O'Meara NM; Shapiro ET; Van Cauter E; Polonsky KS
    Am J Med; 1990 Aug; 89(2A):11S-16S; discussion 51S-53S. PubMed ID: 2117385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
    Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose fluxes and oxidation after an oral glucose load in patients with non-insulin-dependent diabetes mellitus of variable severity.
    Féry F; Melot C; Balasse EO
    Metabolism; 1993 Apr; 42(4):522-30. PubMed ID: 8487677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of hepatic glucose production to growth hormone and severity of malnutrition in a population with colorectal carcinoma.
    Tayek JA; Bulcavage L; Chlebowski RT
    Cancer Res; 1990 Apr; 50(7):2119-22. PubMed ID: 2317802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.
    Wajchenberg BL; Santomauro AT; Giannella-Neto D; Borghi VC; Porrelli RN
    Diabetes Res Clin Pract; 1992 Aug; 17(2):89-97. PubMed ID: 1425152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.